Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

GBS: GBS' Prints Are All Over It

By John Vandermosten, CFA NASDAQ:GBS READ THE FULL GBS RESEARCH REPORT

Benzinga

10 Psychedelics CEOs To Pay Attention To In 2022

By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public.

Benzinga

Expert Ratings for Blink Charging

Blink Charging (NASDAQ:BLNK) has observed the following analyst ratings within the last quarter:

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings for Pennant Gr

Within the last quarter, Pennant Gr (NASDAQ:PNTG) has observed the following analyst ratings:

Benzinga

Where Regency Centers Stands With Analysts

Analysts have provided the following ratings for Regency Centers (NASDAQ:REG) within the last quarter:

Benzinga

Analyzing Nasdaq's Short Interest

Nasdaq's (NASDAQ:NDAQ) short percent of float has risen 5.19% since its last report. The company recently reported that it has 1.62 million shares sold short, which is 1.42% of all regular shares that are available for trading.

Benzinga

Expert Ratings for Sonder Holdings

Sonder Holdings (NASDAQ:SOND) has observed the following analyst ratings within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What 9 Analyst Ratings Have To Say About Intuitive Surgical

Within the last quarter, Intuitive Surgical (NASDAQ:ISRG) has observed the following analyst ratings:

Benzinga

Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants

Moderna Inc (NASDAQ:MRNA) has released new clinical data on its bivalent (omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the omicron subvariants BA.4 and BA.5. The company is working on completing regulatory submissions…

Benzinga

Morgan Stanley Sees Further Share Gains For AMD - Read Why

Morgan Stanley analyst Joseph Moore reinstated Advanced Micro Devices, Inc (NASDAQ: AMD) wi

Benzinga

Why Mullen Automotive Shares Are Gaining Today

Mullen Automotive Inc (NASDAQ:MULN) has filed over 130 patents in 24 countries for Mullen FIVE EV Crossover program. The patent applications are related to the design and styling of the Mullen FIVE EV Crossover, covering its exterior and interior design. The patent applications include 19 U.S. design patent filings and 117 international design…

Benzinga

Uber, Lyft Drivers File Antitrust Case Against Ride Hailing Companies

A group of Uber Technologies, Inc (NYSE:UBER) and Lyft, Inc (NASDAQ:LYFT) drivers slapped an antitrust lawsuit on the companies for unfairly controlling passenger fares. The drivers claimed that lower consumer fares would provide them with "the most competitive compensation." The suit adds that companies hurt driver earnings by charging higher fares to the customers. The lawsuit…

Benzinga

Softbank Continues To Lose Key Official In Quick Succession

Softbank Group Corp (OTC:SFTBY) (OTC:SFTBF) SoftBank Group International named SBGI Managing Partner Alex Clavel as CEO, effective June 30. Clavel, a seven-year veteran in the company, succeeded Michel Combes, who departed to pursue new opportunities after five years in the company. Combes had assumed the CEO position five months back, succeeding former SoftBank…

Benzinga

Jim Cramer Shares His Takes On Marathon Oil, T Rowe Price Group And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Marathon Oil Corp (NYSE: MRO) because he likes the oils. But he recommended not getting greedy.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Read Why This Analyst Cut Bed Bath And Beyond's Price Target By 60%

Telsey Advisory Group analyst Cristina Fernández lowered the price target on Bed Bath & Beyond Inc (NASDAQ:BBBY) to $6 from $15, implying a 10.45% downside. The analyst maintained an Underperform rating on the shares. The analyst is taking a subdued view due to more negative commentary from mass retailers like Big Lots, Inc. (NYSE:BIG), Target Corp (NYSE:TGT), and Walmart Inc (NYSE:WMT)…

Benzinga

Options Traders Expect Tesla To Zoom Ahead

Shares of Tesla Inc (NASDAQ: TSLA) spiked on Tuesday after the company announced layoffs amid supply chain bottlenecks.

Benzinga

Is Facebook Losing Out To TikTok? Brazilian Investment Bank Liquidates 4-Year Long Position In Meta

Meta Platforms, Inc. (NASDAQ: META) stock is slowly losing its appeal among institutional investors amid its recent fundamental setbacks.

Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Quotient Stock Is Soaring Today

Quotient Ltd (NASDAQ: QTNT) shares are trading higher Wednesday after the company issued guidance above analyst estimates. Quotient announced that it has rescheduled its financial results to June 24. The company provided a preview of its results in accordance with the rescheduling.

Benzinga

How To Watch YouTube Videos On Apple Watch For Free

Apple Inc’s (NASDAQ: AAPL) smartwatch comes with many features — sending text messages, making phone calls and listening to music. But for things like watching videos, people mostly used their iPhones — this might change now.

Benzinga

Ikena Oncology Secures Fast Track designation From FDA For Pleural Cancer Candidate

Ikena Oncology, Inc. (NASDAQ: IKNA) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for IK-930, in patients with unresectable NF2-deficient malignant pleural mesothelioma (MPM).

Benzinga

Benzinga Before The Bell: Executive Shakeup At Amazon, Boeing Supply Chain Warning, Apple's Tim Cook Says 'Stay Tuned' On AR/MR And Other Top Financial Stories Wednesday, June 22

CNBC Moderna To establish New Vaccine Facility In Britain

Benzinga

Why Athira Pharma Stock Is Plunging

Athira Pharma Inc (NASDAQ: ATHA) shares are falling Wednesday after the company announced topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton in patients with mild-to-moderate Alzheimer's disease.

Benzinga

Athira Pharma Shares Fall To 52-Week Low - Read Why

Athira Pharma Inc (NASDAQ:ATHA) shares are falling to 52-week lows after announcing disappointing topline results from its exploratory ACT-AD Phase 2 study of fosgonimeton (ATH-1017) in mild-to-moderate Alzheimer's disease (AD). The study did not meet the primary endpoint of a statistically significant change in ERP P300 Latency for the modified intent to treat…

Benzinga

The Valens Company Signs Exclusive Cannabis Partnership With Coldhaus Distribution

The Valens Company Inc. (NASDAQ: VLNS) (TSX: VLNS) has secured an exclusive cannabis partnership with Coldhaus Distribution to provide integrated logistics solutions for Valens-branded cannabis products across Ontario, Alberta, and British Columbia.

1 … 392 393 394 395

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations